In the patient group with low EPLIN expression, the mean OS in tumours responsive to NAC was 36.39 months (95% cl: 20.941–51.839) and that in tumours with no response to NAC was 26.166 months (95% cl: 17.726–34.606 months) (Figure 5C). Here, LIMA1 is linked to neoplasm.